Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity was posted on October 25, 2005. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

A -- Medication Measures for Part D

Awarded
CMS-05-MM-RFP-LMGFederal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Centers for Medicare & Medicaid Services (CMS) plans to issue a Request for Proposal aimed at developing Part D Medication Measures for Prescription Drug Plans and Medicare Advantage Prescription Drug Plans. These measures will target pharmacy and physician levels to facilitate quality improvement, intervention, clinical and economic evaluation, and public reporting regarding the Part D benefit. The development efforts will align with the Institute of Medicine's domains of safety, effectiveness, patient-centeredness, timeliness, efficiency, and equity, focusing on a limited number of measures related to specific disease states and drug classes. Approximately two disease states and up to ten drugs or drug classes will be included, addressing categories such as avoidable drug use in the elderly, generic prescribing ratios, disease-specific therapy, appropriate prescribing for conditions like cardiovascular diseases, cost-effective drug utilization, quality assurance for reducing medication errors, and controlling fraud and waste. Qualified contractors must have existing licenses and expertise in systems like Medispan or First Data Bank to apply. The contract’s term is set for 12 months under the North American Industry Classification System code 541710. The solicitation, referenced as CMS-05-MM-RFP-LMG, was scheduled for release shortly after the announcement and is available for review on the federal business opportunities website. The designated contact for this opportunity is Linda H Gmeiner, a CMS Contract Specialist, who can be reached via email or phone for further inquiries.

General Info

CMS seeks contractors to develop Part D medication quality measures for drug plans, focusing on safety and efficiency.

Agency

N/A

Contract Value

$1,307,323

NAICS

541710 - Research and Development in the Physical, Engineering, and Life Sciences

Place of Performance

VA, USA

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Sources Sought

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Linda H GmeinerContract Specialist

Full Description

Show more
The Centers for Medicare & Medicaid Services (CMS) intends to issue a Request for Proposal (RFP) to develop Part D Medication Measures at the Prescription Drug Plans (PDPs) and/or Medicare Advantage Prescription Drug Plans (MA-PDPs), pharmacy and/or physician level that can be used for quality improvement and intervention, evaluation and monitoring of the clinical and economic impact of the Part D benefit, and for public reporting purposes. The measures (to the extent feasible) shall be based on the Institute of Medicine's (IOMs) domains of safety, effectiveness, patient-centered, timeliness, efficiency and equitability. A limited number of measures shall be developed that focus on specific categories/subcategories. The measures shall be limited to approximately two specific disease states and up to 10 specific drugs or drug classes. The categories/subcategories are: 1. Prescribing Use of avoidable drugs in elderly; Generic prescribing ratios; Use of selected medications within certain therapeutic categories; 2. Disease-specific therapy Drug-disease interaction; Therapeutic monitoring associated with specific drug utilization; 3. Appropriateness of Therapy Measures'appropriate prescribing and drug regimen for specified disease states such as: Cardiovascular (Heart Failure, Coronary Artery Disease/Acute Myocardial Infarction, Artial Fibrillation, and Hypertension); Second disease state will be determined by CMS; 4. Cost effective drug utilization management/economic impact; 5. Quality assurance to reduce medication errors and adverse drug interactions and improve medication use; and 6. Controlling fraud, abuse and waste. Interested sources must possess an existing license and expertise in the use of Medispan, First Data Bank or other comparable system. The period of performance is 12 months. The North American Industry Classification System (NAICS) Code is 541710. RFP Number CMS-05-MM-RFP-LMG is anticipated to be released 15 days from the date of publication of this notice and will be made available at www.fedbizopps.gov.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS